Crossmark

Loxoprofen overdose without toxicity: pharmacokinetics of loxoprofen and metabolites analysed by liquid chromatography–mass spectrometry: a case report

Crossref DOI link: https://doi.org/10.1186/s12245-026-01256-4

Published Online: 2026-05-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mori, Daiki

Tachino, Jotaro

Harada, Kazuo

Ueki, Miyu

Minami, Kensuke

Takegawa, Ryosuke

Hirose, Tomoya

Nakao, Shota

Matsumoto, Hiroshi

Oda, Jun
License Information

Text and Data Mining valid from 2026-05-29

Accepted Manuscript valid from 2026-05-29
More Information

Article History

Received: 7 February 2026

Accepted: 22 May 2026

First Online: 29 May 2026

Declarations

:

: This study was approved by the Research Ethics Board of the University of Osaka (approval no. 25547) and was conducted in accordance with the principles of the Declaration of Helsinki. Written informed consent to participate was obtained from the patient.

: Written informed consent was obtained from the patient for the publication of this case report.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below